ACE2 and COVID-19: In addition to DNAm, the role of histone modifications, particularly transcription-repressing marks, has also been implicated in COVID-19, especially in the regulation of antiviral interferon response and transcription of interferon-stimulated genes such as ACE2 and IL6 [9], which are deregulated in patients with severe COVID-19.